Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trials

June 4, 2025

Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for psoriasis and atopic dermatitis. The company has decided to discontinue development of the drug. Separately, a surprise FDA inspection is underway at Sun Pharma’s Halol manufacturing facility.

More To Explore

12 equity mutual funds with over Rs 1,000 NAV offer upto 24% CAGR since their inception. Do you own any?

Out of these 12 funds, 11 have been in the market for more than 25 years. They have delivered consistent double-digit returns over decades, highlighting

March 4, 2026

80% of Indian stocks are in bear market. Is it time to be greedy or fearful?

Nearly 80% of Indian stocks are deep in bear market territory, hidden beneath modest index declines. Small and midcap companies have faced prolonged selling, but

March 4, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003